| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.44 | 0.0004 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |